ADAPTIVE PHAGE THERAPEUTICS

Lobbying client · Maryland · filed 2025 to 2025

Life sciences company developing treatments for drug resistant bacteria.

$0 Reported spend

2 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page comes from one LDA client record (205428), filed by the registrant listed below.

Who filed for this client 1

MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC) $0 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2025 $0 2 filings

Recent filings 2 total

Q2 terminationNo activity

MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)

2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 20, 2025

View → Q1 reportNo activity

MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)

1st Quarter 2025 (Jan 1 - Mar 31) · posted Apr 21, 2025

View →

Keep going

Filings through July 20, 2025, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.